Follow us on Twitter
This page is updated frequently with new Noma-related patent applications. Subscribe to the Noma RSS feed to automatically get the update: related Noma RSS feeds. RSS updates for this page: Noma RSS
Procurement process utilizing a light sensor
Method for quantitative definition of direct hydrocarbon indicators
Water enucleation of the prostate
|| List of recent Noma-related patents
|Distributed network anomaly detection|
A network device may include multiple interfaces, each including a local database to store, in a first group of local records, information associated with a first group of data units sent from or received by a first one of the group of interfaces; a global database to store, in a group of global records, information associated with the first group of data units and information associated with a second group of data units sent from or received by a second one of said group of interfaces. The device may include a processor, to manage the local database and the global database; broadcast at least one of the local records to the second one of the group of interfaces; and analyze each of the local records to identify potential anomalies in the first group of data units..
|Procurement process utilizing a light sensor|
A system for managing a procurement process uses an ambient light sensor to detect an operating anomaly regarding at least one light source. A procurement system operatively coupled to the light sensing system receives information indicative of the detected operating anomaly of the at least one light source and, in response thereto, initiates the procurement process to obtain a replacement for the at least one light source..
|Method for quantitative definition of direct hydrocarbon indicators|
Method for automated and quantitative assessment of multiple direct hydrocarbon indicators (“dhi's”) extracted from seismic data. Dhi's are defined in a quantitative way (33), making possible a method of geophysical prospecting based on quantification of dhi anomalies.
|Water enucleation of the prostate|
Embodiments of the present invention provide improved methods and apparatus of treating the prostate. In many embodiments, at least a portion of the prostate is enucleated with a water jet, in order to decrease the invasiveness of the surgery.
|Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof|
The present invention provides a series of derivatives of stilbenoid which are useful as new inhibitory agents against head and neck squamous cell carcinoma (hnscc) and hepatoma.. .
|Cdk9 inhibitors in the treatment of midline carcinoma|
The present invention relates to a cdk9 inhibitor, especially a selective cdk9 inhibitor, for use in treating, ameliorating and/or preventing midline carcinoma. Also corresponding methods for treating, preventing or ameliorating midline carcinoma are subject of the present invention.
|Modulation of pancreatic beta cell proliferation|
Work described herein provides, in one embodiment, a method for increasing proliferation or replication of pancreatic beta cells in a subject in need thereof, comprising administering to said subject an effective amount of an agent that increases the level or activity of hepatocellular carcinoma-associated protein td26 (td26), thereby increasing proliferation or replication of pancreatic beta cells. Such an agent may function by, for example, increasing the level of active td26 in the subject or by increasing the functional activity of td26 in the subject..
|Gene signature for the prediction of nf-kappab activity|
Methods for predicting nf-kappab (nf-kb) activity in a tumor, and more particularly to methods for predicting survival and therapeutic outcome, and selecting therapy in subjects with tumors, e.g., adenocarcinomas, e.g., lung adenocarcinomas and melanomas.. .
|Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume|
Novel antibodies and antigen binding fragments that specifically bind to clusterin are described. In some embodiments, the antibodies block the biological activity of clusterin and are useful in composition in certain cancers, more particularly in cancers, such as endometrial carcinoma, breast carcinoma, hepatocellular carcinoma, prostate carcinoma, a renal cell carcinoma, ovarian carcinoma, pancreatic carcinoma, and colorectal carcinoma.
|Induction of thyroid iodide-handling gene expression in human cancers|
Dual suppression of the map kinase and pi3k/akt pathways showed synergistic or greatly enhanced anti-melanoma cell effects, compared to suppression of a single pathway, including the inhibition of cell proliferation, transformation and invasion, induction of g0/g1 cell cycle arrest and, importantly, cell apoptosis. Remarkably, suppression of either pathway induces the expression of thyroid iodide-handling genes and dual suppression of the two pathways synergistically and robustly induces expression of these genes, accompanied by uptake of radioiodine in the cells.
|In-situ battery monitoring system|
The present disclosure provides a system, method, and apparatus for battery monitoring. In one or more embodiments, the disclosed method involves injecting at least one test signal into a battery, and receiving at least one response signal from the battery.
|Smart solenoid compound gun driver and automatic calibration method|
A device for calibrating a spray gun and an associated method are provided. The spray gun has a nozzle that is opened and closed by moving an internal needle out of and into sealing engagement with the nozzle.
|Data-agnostic anomaly detection|
This disclosure presents computational systems and methods for detecting anomalies in data output from any type of monitoring tool. The data is aggregated and sent to an alerting system for abnormality detection via comparison with normalcy bounds.
|Universal smart energy transformer module|
A universal smart energy transformer module (usetm) that uses an array of sensors to monitor and measure characteristics of the electrical power delivered and utilized at a location, along with other conditions in the area surrounding the location. The invention then uses the data from these sensors to determine the condition and performance of the transformer (for example, its input and output, power quality etc.) and also to identify any anomalies detected within the local power system that could threaten reliable electric supply on the electric grid, or pose a danger to people.
|Layer structure for epidermal radionuclide therapy|
Disclosed is a layer structure for epidermal radionuclide therapy (brachytherapy) of a patient comprising, from a patient's view, a proximal adherent layer for applying the layer structure on the skin surface to be treated of a patient; a flexible, transparent carrier layer that from a patient's view is located in a distal direction on the adherent layer; and at least one radionuclide-containing emission layer located on the carrier layer, the adherent layer and the carrier layer with regard to their components and thickness being formed such that they are essentially transparent for β and γ radiation. The layer structure is suited particularly for radiotherapeutic treatment of the basal-cell carcinoma (bcc) and the squamous cell carcinoma (scc).
|Methods for early detection of esophageal cancer|
The present invention relates to a method for screening, predicting or prognosing esophageal adenocarcinoma/high grade dysplasia in a subject.. .
|Mitigation of plugging in hydroprocessing reactors|
The behavior of a monitored condition over time for a reactor or reaction system can be analyzed using groupings or windows of data to identify anomalous features in the time-average values. Anomalous features can be identified based on a threshold value generated from the analysis.
|Renal cell carcinoma biomarkers|
Disclosed herein is a method of identifying a tumor biomarker. In one example, a tumor biomarker is identified by obtaining a peripheral biological fluid sample from a subject with a tumor as well as a tumor sample and an adjacent non-tumor sample from such subject.
|Transdermal propranolol patch for treatment of malignant melanoma|
A transdermal d propranolol or racemic propranolol patch for use as an adjunct to surgery in the treatment of malignant melanoma and/or tattoo related applications are herein disclosed.. .
|Method, machine, and computer medium having computer program to detect and evaluate structural anomalies in circumferentially welded pipelines|
Embodiments of the present invention provide methods, machines, and a computer medium or media having computer programs to determine presence anomalies in circumferential welds of one or more pipelines transporting fluids associated with energy therethrough. Wave form analysis or pattern recognition in pipeline data such as magnetic flux leakage data is employed.
|Nanomaterials fabricated using spark erosion and other particle fabrication processes|
Methods, systems, and devices are disclosed for fabricating clean, oxidation-free nanoparticles of electrically conducting metals and alloys using spark erosion techniques. In one aspect, a method includes dispersing bulk pieces of an electrically conducting material in a dielectric fluid with mechanical vibrations within a container; generating an electric field using electrodes in the dielectric fluid using by an electric pulse, in which the electric field creates a plasma in a volume existing between the bulk pieces that locally heats the bulk pieces to form structures within the volume, the dielectric fluid quenching the structures to form nanoparticles, and filtering the nanoparticles through a screen including holes of a size allowing nanoparticles of the size or smaller to pass through the screen to a region in the container, in which the dielectric fluid inhibits oxidation of the surface of the nanoparticles..
|System and method for integrated header, state, rate and content anomaly prevention for session initiation protocol|
Methods and systems for an integrated solution to the rate based denial of service attacks targeting the session initiation protocol are provided. According to one embodiment, header, state, rate and content anomalies are prevented and network policy enforcement is provided for session initiation protocol (sip).
|Methods and systems for planning execution of an application in a cloud computing system|
Methods and systems related to planning an execution of an application in a cloud computing system are described herein. The method includes determining whether a workload causes an anomaly associated to the execution of an application.
|Methods and systems for detecting anomaly in passenger flow|
Methods and systems for detecting an anomaly in a passenger flow towards a transport device. Historical data relating to the passenger flow is aggregated and a forecast passenger flow value for a target time frame is determined based upon the historical data.
|Compositions and methods of treatment of inflammatory skin conditions using allantoin|
Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof.
|Compounds and methods for kinase modulation, and indications therefor|
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one raf protein kinase.
|Method of diagnosing neoplasms - ii|
The present invention relates generally to nucleic acid molecules in respect of which changes to the dna or to the rna or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the dna or to the rna or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma.
|Susceptibility to selective cdk9 inhibitors|
The present invention relates to a method of selecting (a) cell(s), (a) tissue(s) or (a) cell culture(s) with susceptibility to a selective cdk9 inhibitor. Also a method for determining the responsiveness of a mammalian tumor cell or cancer cell to treatment with a selective cdk9 inhibitor is described herein.
|Acf detection method|
The present invention provides a method for detecting acf by analyzing a test region of large intestine tissue at the molecular level. Namely, the present invention relates to a method for detecting aberrant crypt foci (acf) that comprises detecting an acf detection marker in a test region of large intestine tissue, by using one or more types of molecules for which acf-specific expression increases as the acf detection marker, the molecule being selected from the group consisting of slc2a1, and slc7a7; an acf detection marker for detecting the acf in human-derived large intestine tissue, that is slc2a1, or slc7a7; and, a method for evaluating risk of colorectal cancer and colorectal adenoma in subjects based on the results of detecting acf in a test region of large intestine tissue of the subjects using the aforementioned acf detection method..
|Methods and systems for selectively forming metal layers on lead frames after die attachment|
Methods and systems are disclosed for selectively forming metal layers on lead frames after die attachment to improve electrical connections for areas of interest on lead frames, such as for example, lead fingers and down-bond areas. By selectively forming metal layers on areas of interest after die attachment, the disclosed embodiments help to eliminate anomalies and associated defects for the lead frames that may be caused by the die attachment process.
Popular terms: [SEARCH]
Follow us on Twitter
This listing is a sample listing of patent applications related to Noma for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Noma with additional patents listed. Browse our RSS directory or Search for other possible listings.